Johnson & Johnson (JNJ) says it will buy Swiss medical-device maker Synthes for $21.3B (1/3...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson (JNJ) says it will buy Swiss medical-device maker Synthes for $21.3B (1/3 cash, 2/3 stock - a 22% premium), giving it a commanding lead in the global market for surgical devices used to treat bone fractures and trauma. It's unclear whether Synthes' shareholders will be satisfied with the price.